Zhejiang Taimei Medical Technology Co., Ltd. (HKG:2576)

Market Cap	2.71B +4.1%
Revenue (ttm)	572.65M -8.8%
Net Income	-72.63M
EPS	-0.13
Shares Out	563.61M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,400
Average Volume	44,690
Open	4.820
Previous Close	4.800
Day's Range	4.700 - 4.820
52-Week Range	3.060 - 5.310
Beta	n/a
RSI	55.51
Earnings Date	Mar 30, 2026

About HKG:2576

Zhejiang Taimei Medical Technology Co., Ltd. provides digital operation platform for the biopharma industry in China. The company offers TrialOS, a drug digital cooperation platform that connects the cycle of hospitals, pharmaceutical companies, third-party providers, regulatory authorities, patients, and other industry stakeholders; PharmaOS, a pharmaceutical digital marketing platform; and Enterprise-Medical Academic Interaction Platform, an enterprise-medical communication. It also provides software solutions, such as eCollect, an electronic...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2013
• Employees: 656
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2576

Financial Performance

In 2024, HKG:2576's revenue was 551.16 million, a decrease of -3.84% compared to the previous year's 573.14 million. Losses were -214.61 million, -38.11% less than in 2023.

Financial numbers in CNY